Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Annales Pharmaceutiques Francaises is Scopus-indexed (Q3, CiteScore 2.4), WoS ESCI. Published by Elsevier Masson s.r.l..
Checked against the index lists dated .
ISSN 0003-4509Verify ISSN ↗
Publisher: Elsevier Masson s.r.l.
Cost to publish: About US$3,000 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 111 / 191 | 42nd | Q3 |
| Pharmacology | 234 / 328 | 28th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1947–present (also 1945), best quartile Q3, CiteScore 2.4.
Annales Pharmaceutiques Francaises is Q3 in Pharmaceutical Science (rank 111 of 191) and Q3 in Pharmacology (rank 234 of 328), by CiteScore 2025.
Annales Pharmaceutiques Francaises is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.4, which places it in quartile Q3 at the 42nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.278, quartile Q3, with an H-index of 36.
The publisher lists an article processing charge of about US$3,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Annales Pharmaceutiques Francaises is published by Elsevier Masson s.r.l. Its ISSN is 0003-4509.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Annales Pharmaceutiques Francaises has an h-index of 37 and a 2-year mean of 1.49 citations per paper (OpenAlex). Its Scopus CiteScore is 2.4, quartile Q3. On 2-year citations it ranks #92 of 177 Scopus journals in Pharmaceutical Science.
Annales Pharmaceutiques Francaises published 122 papers in 2025; its busiest recent year was 2024 with 125. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 88 research articles (2025–2026), authors are most often from France (39%), India (33.9%) and Canada (5.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.